Headquartered in The Hague, Netherlands, Micreos is focused on developing targeted antibacterial products to replace antibiotics, protect against food contamination and treat inflammatory skin conditions. The firm’s Gladskin Eczema Cream, now available stateside, uses a patented enzyme technology to destroy Staphylococcus aureus bacteria while leaving skin’s beneficial flora intact.
Gladskin Eczema Cream, now available to US consumers, not only relieves itch and redness associated with the condition, but also addresses imbalances in skin’s microbiome that contribute to eczema flare-ups, the brand says.
Targeting the estimated 30 million Americans suffering from eczema – both adults and children as young as three months –...